Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
fda
2
×
life sciences
national blog main
2
×
rare disease drugs
2
×
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
autoimmune disorders
biotech ipos
complement system
deals
dyne therapeutics
generalized myasthenia gravis
immune-mediated necrotizing myopathy
metacrine
myotonic dystrophy type 1
nonalcoholic steatohepatitis
ra pharmaceuticals
rare diseases
salk institute
san diego blog main
san diego top stories
ucb
ulcerative colitis
zilucoplan
What
drug
2
×
medicines
alternative
autoimmune
brings
candidate
company
deal
developing
disease
disorders
dyne
dyne’s
expensive
genetic
ipo
lead
million
muscle
muscular
pharma
pharmaceuticals
potential
preclinical
ra
raised
rare
stage
stakes
territory
therapeutics
topped
ucb
upsized
viewed
world
Language
unset
Current search:
fda
×
drug
×
" national blog main "
×
boston
×
" rare disease drugs "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
